Breast Cancer Gene Mutation Prevalence

publication

Hypothesis

What is the prevalence of BRCA1 and BRCA2 mutations among breast cancer patients and the general population?

Conclusion

The study found that 2.4% of breast cancer patients had BRCA1 mutations and 2.3% had BRCA2 mutations, with lower prevalence rates in the general population.

Supporting Evidence

2.4% of breast cancer patients had BRCA1 mutations.
2.3% of breast cancer patients had BRCA2 mutations.
0.06% of the general population had BRCA1 mutations.
0.4% of the general population had BRCA2 mutations.

Takeaway

This study shows that a small number of women with breast cancer have specific gene mutations, which can increase their risk of the disease.

Participant Demographics

The study included breast cancer patients and white and black women aged 35 to 64 in the general population.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication

Home